Literature DB >> 6853104

Identification of accommodative vergence contribution to the near response using response variance.

G K Hung, J L Semmlow, K J Ciuffreda.   

Abstract

An experimental method was developed to isolate accommodative and disparity vergence contributions to coordinated near vergence motor responses. The variability normally associated with the neural control signal was used as an identifying marker or tag. Using this approach, the results showed an increased variability associated with the blur-driven, accommodative vergence component that is particularly noticeable during the latter half of the movement. This indicated that accommodative vergence provides a moderate contribution to the near vergence response primarily in the late and post-transient period when the movement is essentially complete. Presence of this accommodative contribution lends further support to the "dual interactive model" of near triad control.

Mesh:

Year:  1983        PMID: 6853104

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  4 in total

1.  The first and second order dynamics of accommodative convergence and disparity convergence.

Authors:  James Maxwell; Jianliang Tong; Clifton M Schor
Journal:  Vision Res       Date:  2010-06-01       Impact factor: 1.886

2.  Short-term adaptations of the dynamic disparity vergence and phoria systems.

Authors:  Eun H Kim; Vincent R Vicci; Bérangère Granger-Donetti; Tara L Alvarez
Journal:  Exp Brain Res       Date:  2011-05-19       Impact factor: 1.972

3.  Sustained fixation induced changes in phoria and convergence peak velocity.

Authors:  Eun H Kim; Vincent R Vicci; Sang J Han; Tara L Alvarez
Journal:  PLoS One       Date:  2011-06-17       Impact factor: 3.240

4.  Determining the relative contribution of retinal disparity and blur cues to ocular accommodation in Down syndrome.

Authors:  Lesley Doyle; Kathryn J Saunders; Julie-Anne Little
Journal:  Sci Rep       Date:  2017-01-10       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.